Form D · Pharmaceuticals
Sincerus Pharmaceuticals Inc
Pompano Beach, FL · CIK 0001771772
Offering snapshot reported Mar 28, 2019 · SEC filing
- Reported sold
- $506K Offering amount: $2M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Mar 13, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 28, 2019 | Initial | $505,504 | No comparison | 24 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-335894
Source: Form D, filed Mar 28, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jonathan G. Fenster | Director, Executive |
| Michael Gleit | Director |
| Spencer J. Malkin | Director, Executive |
| Barret S. Malkin | Director, Executive |
| Louis Jack Staley | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3265 W Mcnab Road
Pompano Beach, FL, 33069
Pompano Beach, FL, 33069